VANI
Vivani Medical, Inc.
NASDAQ · Healthcare · Medical - Devices · US
$1.06
+0.48%Price chart
Oct 6Oct 9Oct 14Oct 19Oct 22Oct 27Oct 30Nov 4
Key dataNov 4, 2026
Open$1.08
From 52W high−34.06%
Volume140225.00
Market cap$95.16M
P/E (TTM)—
P/S (TTM)—
Div yield—
Key dataNov 4, 2026
Open
$1.08
From 52W high
−34.06%
Volume
140225.00
Market cap
$95.16M
ValuationView details →
P/E (Fwd)
—
EV/EBITDA
−3.5x
P/E (TTM)
—
RSI (14)
31.9
MomentumView details →
1D Return
+0.48%
YTD Return
−14.50%
SummaryUpdated Jun 1, 2026
Vivani Medical, Inc. (NASDAQ:VANI) is a clinical-stage medical device company founded in 2014 and headquartered in Emeryville, California. The company went public in November 2014 and focuses on developing innovative implantable medical devices to address chronic diseases with significant unmet medical needs. Vivani operates as a pre-revenue company, dedicating its resources to advancing two primary technology platforms through clinical development stages.
Similar companies
Latest newsMore news →
Vivani Medical announced it is preparing to begin human testing of its semaglutide implant in August.112d agoNovo Nordisk signed an agreement with Vivani Medical to evaluate Vivani's experimental NPM-139 implant for continuous semaglutide delivery.116d agoVivani Medical signed an agreement with Novo Nordisk to enable Novo Nordisk to evaluate NPM-139, a semaglutide drug implant for chronic weight management.120d ago